AR092939A1 - Vacuna contra cooperia - Google Patents

Vacuna contra cooperia

Info

Publication number
AR092939A1
AR092939A1 ARP130103642A ARP130103642A AR092939A1 AR 092939 A1 AR092939 A1 AR 092939A1 AR P130103642 A ARP130103642 A AR P130103642A AR P130103642 A ARP130103642 A AR P130103642A AR 092939 A1 AR092939 A1 AR 092939A1
Authority
AR
Argentina
Prior art keywords
nucleotide sequences
cooperia
proteins
methods
recombinant dna
Prior art date
Application number
ARP130103642A
Other languages
English (en)
Inventor
Claerebout Edwin
Vercruysse Jozef
Geldhof Peter
Borloo Jimmy
Original Assignee
Univ Gent
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Gent filed Critical Univ Gent
Publication of AR092939A1 publication Critical patent/AR092939A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0003Invertebrate antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/545Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Secuencias de nucleótidos que codifican antígenos de Cooperia, así como con moléculas de ADN recombinante que contienen a dichas secuencias de nucleótidos y con células huésped que expresan estas secuencias de nucleótidos. Se relaciona además con proteínas de Cooperia, con métodos para la producción de las proteínas, las secuencias de nucleótidos, moléculas de ADN recombinante y huéspedes. Aún más, se relaciona con vacunas que inducen una inmunidad protectora contra una infección por nematodos parásitos tales como especies del género Cooperia y con métodos para preparar dicha vacuna. Vector, uso, método de vacunación.
ARP130103642A 2012-10-09 2013-10-08 Vacuna contra cooperia AR092939A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP12187773 2012-10-09

Publications (1)

Publication Number Publication Date
AR092939A1 true AR092939A1 (es) 2015-05-06

Family

ID=47018872

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP130103642A AR092939A1 (es) 2012-10-09 2013-10-08 Vacuna contra cooperia

Country Status (7)

Country Link
US (2) US10105424B2 (es)
EP (1) EP2906588B1 (es)
AR (1) AR092939A1 (es)
BR (1) BR112015007678B1 (es)
CA (1) CA2886450C (es)
ES (1) ES2717441T3 (es)
WO (1) WO2014056885A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR092939A1 (es) * 2012-10-09 2015-05-06 Univ Gent Vacuna contra cooperia
AU2018324195A1 (en) 2017-09-01 2020-04-02 Venn Biosciences Corporation Identification and use of glycopeptides as biomarkers for diagnosis and treatment monitoring
WO2024089248A1 (en) * 2022-10-27 2024-05-02 Universiteit Gent Recombinant activation-associated secreted protein

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5084269A (en) 1986-11-06 1992-01-28 Kullenberg Fred W Adjuvant for dose treatment with antigens
DE69101683T2 (de) 1990-07-30 1994-07-21 Akzo Nv Rekombinantes Mareks-Krankheitsvirus.
US5525508A (en) 1991-02-06 1996-06-11 Biotech Australia Pty Limited Haemonchus contortus vaccine
US6071518A (en) * 1992-05-29 2000-06-06 The Regents Of The University Of California GP900 glycoprotein and fragments for treatment and detection/diagnosis of cryptosporidium
US5961970A (en) 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
WO1998001550A2 (en) 1996-07-04 1998-01-15 Universiteit Utrecht Vaccine against gastro-intestinal nematodes
KR20090051129A (ko) 2004-04-05 2009-05-20 화이자 프로덕츠 인코포레이티드 미세유체화된 수중유 유화액 및 백신 조성물
WO2009158729A2 (en) * 2008-06-27 2009-12-30 The Infectious Disease Research Institute Inc. Compounds and methods for diagnosis and treatment of chagas disease
CA2739796C (en) 2008-10-08 2018-11-06 Idexx Laboratories, Inc. Compositions and methods for detection of antibodies specific for anaplasma phagocytophilum (aph) and anaplasma platys (apl)
GB0922099D0 (en) 2009-12-18 2010-02-03 Moredun Res Inst Parasite Vaccine
AR092939A1 (es) * 2012-10-09 2015-05-06 Univ Gent Vacuna contra cooperia

Also Published As

Publication number Publication date
US20180369349A1 (en) 2018-12-27
WO2014056885A1 (en) 2014-04-17
US10946077B2 (en) 2021-03-16
US10105424B2 (en) 2018-10-23
EP2906588B1 (en) 2018-12-05
CA2886450A1 (en) 2014-04-17
ES2717441T3 (es) 2019-06-21
CA2886450C (en) 2021-10-26
US20150265687A1 (en) 2015-09-24
BR112015007678A2 (pt) 2017-08-08
EP2906588A1 (en) 2015-08-19
BR112015007678B1 (pt) 2022-12-13

Similar Documents

Publication Publication Date Title
CO2018005265A2 (es) Vacunas de ácido nucleico para el virus varicela-zóster
BR112018008090A2 (pt) vacina de vírus do herpes simplex.
BR112013020070A2 (pt) moléculas de ácido nucleico que codificam novos antígenos de herpes, vacina compreendendo as mesmas e métodos de uso das mesmas
MX2022006603A (es) Vacuna contra el virus de la influenza de amplio espectro.
EA201891415A8 (ru) Антигены вируса иммунодефицита человека, векторы, композиции и способы их применения
PE20142406A1 (es) Antigenos asociados a prostata y regimenes de inmunoterapia basados en vacuna
MX346245B (es) Proteina de fusion que comprende el mutante crm197 no toxico de toxina de difteria.
MX2018010483A (es) Inmunogenos para vacunacion contra vih.
BR112012030746A2 (pt) cepas hospedeiras fúngigas filamentosas e constructos de dna , e métodos de uso dos mesmos.
PH12015500308A1 (en) Hepatitis b virus core protein and surface antigen protein and vaccine comprising the same
CO2018012513A2 (es) Anticuerpos
EA202092990A2 (ru) Молекула нуклеиновой кислоты, кодирующая коровый белок вируса гепатита в, и вакцина, содержащая указанную молекулу
BR112015000585A2 (pt) cepas mutantes de mycoplasma hyopneumoniae
MX2016013631A (es) Celulas huespedes modificadas y usos de las mismas.
PE20160662A1 (es) Anticuerpos especificos para fcrn
MX2016006758A (es) Composiciones y metodos de vectores para inducir una respuesta inmunitaria mediante el uso de vectores de poxvirus.
UY36617A (es) Proteínas de fusión inmunogénicas para el tratamiento del cáncer
BR112017004495A2 (pt) variantes de celobiohidrolase e polinucleotídeos codificando as mesmas
MX2015013304A (es) Vacunas de nucleoproteina de la influenza.
AR092939A1 (es) Vacuna contra cooperia
PH12017501100B1 (en) Recombinant swinepox virus and vaccines
BR112014014390A2 (pt) levedura recombinante, seus usos, processo para vacinação, oligonucleotídeo, vetor de expressão, e método de produção de uma composição de vacina
CU20150019A7 (es) Rotavirus humanos modificados
PL406631A1 (pl) Antygen, szczepionka przeciwko grypie, układ do wytwarzania szczepionki, sposób wytwarzania antygenu oraz zastosowanie antygenu określonego powyżej do wytwarzania szczepionki przeciwko grypie
WO2012178078A3 (en) Use of yscf, truncated yscf and yscf homologs as adjuvants

Legal Events

Date Code Title Description
FG Grant, registration